Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Literature
1.
Parr SK, Matheny ME, Abdel-Kader K, Greevy RA Jr, et al. Acute kidney injury is a risk factor for subsequent proteinuria. Kidney Int. 2018;93(2):460–9.CrossRef
2.
Sharma A, Mucino MJ, Ronco C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract. 2014;127(1–4):94–100.CrossRef
3.
Koratala A, Kazory A. Pregnancy outcomes in “recovered” acute kidney injury: underscoring renal functional reserve. Nephron. 2017;136(3):243–4.CrossRef
4.
Mogensen CE. Glomerular hyperfiltration in human diabetes. Diabetes Care. 1994;17(7):770–5.CrossRef
5.
Westland R, Schreuder MF, van Goudoever JB, Sanna-Cherchi S, et al. Clinical implications of the solitary functioning kidney. Clin J Am Soc Nephrol. 2014;9(5):978–86.CrossRef
Metadata
Title
Reduced renal functional reserve as the mechanism linking acute kidney injury to proteinuria
Authors
Abhilash Koratala
Mayanka Kamboj
Publication date
01-12-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 6/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1558-2

Other articles of this Issue 6/2018

Clinical and Experimental Nephrology 6/2018 Go to the issue

Invited review article

Independent regulation of renin–angiotensin–aldosterone system in the kidney

Original article

Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study

Original article

Calcium-sensing receptor (CaSR) modulates vacuolar H+-ATPase activity in a cell model of proximal tubule

Images in Nephrology

Imaging of bilateral Ask-Upmark kidney

Original article

Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis

Original article

Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits